Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
In Reply: We are heartened by the comments
of Drs Ofman and Lubeck, who acknowledge the important role for the pharmaceutical
industry in supporting PCTs that reliably compare risks, benefits, and costs
of competing technologies. We agree that the production of high-quality evidence
will not by itself influence the decisions of consumers, clinicians, and policy
makers. Clearly there is also a need for organizational strategies and systems
that will increase the use of clinical interventions proven to be effective.
Many public and private health care organizations are devoting considerable
attention and resources to the measurement and improvement of health care
Tunis SR, Stryer DB. Realizing the Benefits of Practical Clinical Trials—Reply. JAMA. 2004;291(4):425-426. doi:10.1001/jama.291.4.426